{"id":"https://openalex.org/W7125589136","doi":"https://doi.org/10.1208/s12249-026-03349-y","title":"High Shear Wet Granulation Process Common Deficiencies Observed in Recently Submitted New and Abbreviated Drug Applications","display_name":"High Shear Wet Granulation Process Common Deficiencies Observed in Recently Submitted New and Abbreviated Drug Applications","alternate_titles":[],"publication_year":2026,"publication_date":"2026-01-23","ids":{"openalex":"https://openalex.org/W7125589136","doi":"https://doi.org/10.1208/s12249-026-03349-y","pmid":"https://pubmed.ncbi.nlm.nih.gov/41578034"},"language":"en","primary_location":{"id":"doi:10.1208/s12249-026-03349-y","doi":"https://doi.org/10.1208/s12249-026-03349-y","is_oa":false,"landing_page_url":"https://doi.org/10.1208/s12249-026-03349-y","pdf_url":null,"source":{"id":"https://openalex.org/S1234972","display_name":"AAPS PharmSciTech","issn_l":"1530-9932","issn":["1530-9932"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AAPS PharmSciTech","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7125589136"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100995848","display_name":"Lixia Cai","orcid":"https://orcid.org/0009-0002-3828-3491","observed_orcids":["https://orcid.org/0009-0002-3828-3491"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lixia Cai","raw_affiliation_strings":["Division of Pharmaceutical Manufacturing IV/Unit III, FDA/CDER/OPQ/OPMA/DPMIV/UNIT III, 10903 New Hampshire Avenue, White Oak Bldg. 75, Rm. 6676, Silver Spring, Maryland, 20993, USA. lixia.cai@fda.hhs.gov","Office of Pharmaceutical Manufacturing Assessment, Office of Pharmaceutical Quality, CDER, Food and Drug Administration, Silver Spring, Maryland, 20993, USA. lixia.cai@fda.hhs.gov"],"raw_orcid":"https://orcid.org/0009-0002-3828-3491","affiliations":[{"raw_affiliation_string":"Division of Pharmaceutical Manufacturing IV/Unit III, FDA/CDER/OPQ/OPMA/DPMIV/UNIT III, 10903 New Hampshire Avenue, White Oak Bldg. 75, Rm. 6676, Silver Spring, Maryland, 20993, USA. lixia.cai@fda.hhs.gov","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"raw_affiliation_string":"Office of Pharmaceutical Manufacturing Assessment, Office of Pharmaceutical Quality, CDER, Food and Drug Administration, Silver Spring, Maryland, 20993, USA. lixia.cai@fda.hhs.gov","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5146895916","display_name":"Haitao Li","orcid":"https://orcid.org/0009-0004-0477-2670","observed_orcids":["https://orcid.org/0009-0004-0477-2670"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haitao Li","raw_affiliation_strings":["Office of Pharmaceutical Manufacturing Assessment, Office of Pharmaceutical Quality, CDER, Food and Drug Administration, Silver Spring, Maryland, 20993, USA"],"raw_orcid":"https://orcid.org/0009-0004-0477-2670","affiliations":[{"raw_affiliation_string":"Office of Pharmaceutical Manufacturing Assessment, Office of Pharmaceutical Quality, CDER, Food and Drug Administration, Silver Spring, Maryland, 20993, USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5146648044","display_name":"Hang Guo","orcid":"https://orcid.org/0009-0006-1145-6419","observed_orcids":["https://orcid.org/0009-0006-1145-6419"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hang Guo","raw_affiliation_strings":["Office of Pharmaceutical Manufacturing Assessment, Office of Pharmaceutical Quality, CDER, Food and Drug Administration, Silver Spring, Maryland, 20993, USA"],"raw_orcid":"https://orcid.org/0009-0006-1145-6419","affiliations":[{"raw_affiliation_string":"Office of Pharmaceutical Manufacturing Assessment, Office of Pharmaceutical Quality, CDER, Food and Drug Administration, Silver Spring, Maryland, 20993, USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025627904","display_name":"Steve Y. Rhieu","orcid":"https://orcid.org/0009-0009-2619-2112","observed_orcids":["https://orcid.org/0009-0009-2619-2112"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steve Y. Rhieu","raw_affiliation_strings":["Office of Pharmaceutical Manufacturing Assessment, Office of Pharmaceutical Quality, CDER, Food and Drug Administration, Silver Spring, Maryland, 20993, USA"],"raw_orcid":"https://orcid.org/0009-0009-2619-2112","affiliations":[{"raw_affiliation_string":"Office of Pharmaceutical Manufacturing Assessment, Office of Pharmaceutical Quality, CDER, Food and Drug Administration, Silver Spring, Maryland, 20993, USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086443852","display_name":"Zhouxi Wang","orcid":"https://orcid.org/0009-0002-5196-2309","observed_orcids":["https://orcid.org/0009-0002-5196-2309"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhouxi Wang","raw_affiliation_strings":["Office of Pharmaceutical Manufacturing Assessment, Office of Pharmaceutical Quality, CDER, Food and Drug Administration, Silver Spring, Maryland, 20993, USA"],"raw_orcid":"https://orcid.org/0009-0002-5196-2309","affiliations":[{"raw_affiliation_string":"Office of Pharmaceutical Manufacturing Assessment, Office of Pharmaceutical Quality, CDER, Food and Drug Administration, Silver Spring, Maryland, 20993, USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Feiyan Jin","orcid":"https://orcid.org/0009-0000-5301-1836","observed_orcids":["https://orcid.org/0009-0000-5301-1836"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Feiyan Jin","raw_affiliation_strings":["Office of Pharmaceutical Manufacturing Assessment, Office of Pharmaceutical Quality, CDER, Food and Drug Administration, Silver Spring, Maryland, 20993, USA"],"raw_orcid":"https://orcid.org/0009-0000-5301-1836","affiliations":[{"raw_affiliation_string":"Office of Pharmaceutical Manufacturing Assessment, Office of Pharmaceutical Quality, CDER, Food and Drug Administration, Silver Spring, Maryland, 20993, USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5123734365","display_name":"Qiang Han","orcid":"https://orcid.org/0009-0007-1386-8166","observed_orcids":["https://orcid.org/0009-0007-1386-8166"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qiang Han","raw_affiliation_strings":["Office of Pharmaceutical Manufacturing Assessment, Office of Pharmaceutical Quality, CDER, Food and Drug Administration, Silver Spring, Maryland, 20993, USA"],"raw_orcid":"https://orcid.org/0009-0007-1386-8166","affiliations":[{"raw_affiliation_string":"Office of Pharmaceutical Manufacturing Assessment, Office of Pharmaceutical Quality, CDER, Food and Drug Administration, Silver Spring, Maryland, 20993, USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5100995848"],"corresponding_institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":null,"fwci":1.589,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.71924389,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"27","issue":"2","first_page":"85","last_page":"85"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10615","display_name":"Granular flow and fluidized beds","score":0.9429000020027161,"subfield":{"id":"https://openalex.org/subfields/2206","display_name":"Computational Mechanics"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10615","display_name":"Granular flow and fluidized beds","score":0.9429000020027161,"subfield":{"id":"https://openalex.org/subfields/2206","display_name":"Computational Mechanics"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.020800000056624413,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.014299999922513962,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-shear-wet-granulation","display_name":"high shear wet granulation","score":1.0},{"id":"https://openalex.org/keywords/critical-process-parameters","display_name":"critical process parameters","score":0.6460000276565552},{"id":"https://openalex.org/keywords/process-control","display_name":"process control","score":0.5329999923706055},{"id":"https://openalex.org/keywords/chemistry-manufacturing-and-controls","display_name":"chemistry, manufacturing and controls","score":0.7889999747276306},{"id":"https://openalex.org/keywords/process-scale-up","display_name":"process scale-up","score":0.8009999990463257},{"id":"https://openalex.org/keywords/oral-solid-dosage-forms","display_name":"oral solid dosage forms","score":0.9679999947547913},{"id":"https://openalex.org/keywords/drug-quality","display_name":"drug quality","score":0.7369999885559082},{"id":"https://openalex.org/keywords/fda-regulatory-review","display_name":"FDA regulatory review","score":0.39399999380111694}],"concepts":[{"id":"https://openalex.org/C88463166","wikidata":"https://www.wikidata.org/wiki/Q1543243","display_name":"Granulation","level":2,"score":0.945900022983551},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5827000141143799},{"id":"https://openalex.org/C204320433","wikidata":"https://www.wikidata.org/wiki/Q7268772","display_name":"Quality by Design","level":3,"score":0.5703999996185303},{"id":"https://openalex.org/C2987875673","wikidata":"https://www.wikidata.org/wiki/Q187939","display_name":"Manufacturing process","level":2,"score":0.564300000667572},{"id":"https://openalex.org/C21880701","wikidata":"https://www.wikidata.org/wiki/Q2144042","display_name":"Process engineering","level":1,"score":0.532800018787384},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.5206999778747559},{"id":"https://openalex.org/C91439571","wikidata":"https://www.wikidata.org/wiki/Q1279773","display_name":"Process capability","level":3,"score":0.46399998664855957},{"id":"https://openalex.org/C2780449318","wikidata":"https://www.wikidata.org/wiki/Q18344773","display_name":"Critical quality attributes","level":3,"score":0.46219998598098755},{"id":"https://openalex.org/C2778938233","wikidata":"https://www.wikidata.org/wiki/Q7180757","display_name":"Pharmaceutical manufacturing","level":2,"score":0.4025999903678894},{"id":"https://openalex.org/C178144697","wikidata":"https://www.wikidata.org/wiki/Q2111609","display_name":"Process analytical technology","level":3,"score":0.39649999141693115},{"id":"https://openalex.org/C155386361","wikidata":"https://www.wikidata.org/wiki/Q1649571","display_name":"Process control","level":3,"score":0.38019999861717224},{"id":"https://openalex.org/C2984430287","wikidata":"https://www.wikidata.org/wiki/Q186249","display_name":"Pharmaceutical technology","level":2,"score":0.3684000074863434},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.3273000121116638},{"id":"https://openalex.org/C2777789335","wikidata":"https://www.wikidata.org/wiki/Q18344773","display_name":"Process validation","level":3,"score":0.32330000400543213},{"id":"https://openalex.org/C2988729646","wikidata":"https://www.wikidata.org/wiki/Q838129","display_name":"Process development","level":2,"score":0.313400000333786},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.3098999857902527},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.2985999882221222},{"id":"https://openalex.org/C117671659","wikidata":"https://www.wikidata.org/wiki/Q11049265","display_name":"Manufacturing engineering","level":1,"score":0.2969000041484833},{"id":"https://openalex.org/C2779535233","wikidata":"https://www.wikidata.org/wiki/Q12140","display_name":"Pharmaceutical drug","level":3,"score":0.2939999997615814},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.28369998931884766},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.2766999900341034},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2759999930858612},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.26510000228881836},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.26159998774528503},{"id":"https://openalex.org/C2779709869","wikidata":"https://www.wikidata.org/wiki/Q1292017","display_name":"Good manufacturing practice","level":3,"score":0.258899986743927},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.25200000405311584}],"mesh":[{"descriptor_ui":"D000095485","descriptor_name":"Bulk Drugs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005079","descriptor_name":"Excipients","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011786","descriptor_name":"Quality Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1208/s12249-026-03349-y","doi":"https://doi.org/10.1208/s12249-026-03349-y","is_oa":false,"landing_page_url":"https://doi.org/10.1208/s12249-026-03349-y","pdf_url":null,"source":{"id":"https://openalex.org/S1234972","display_name":"AAPS PharmSciTech","issn_l":"1530-9932","issn":["1530-9932"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AAPS PharmSciTech","raw_type":"journal-article"},{"id":"pmid:41578034","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41578034","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AAPS PharmSciTech","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W971253618","https://openalex.org/W1967463199","https://openalex.org/W2007811123","https://openalex.org/W2022933499","https://openalex.org/W2030117340","https://openalex.org/W2033126233","https://openalex.org/W2045588346","https://openalex.org/W2068160461","https://openalex.org/W2080174674","https://openalex.org/W2091322778","https://openalex.org/W2112180194","https://openalex.org/W2115697004","https://openalex.org/W2789994476","https://openalex.org/W3046506361","https://openalex.org/W3108316206","https://openalex.org/W4283820579","https://openalex.org/W4297338665","https://openalex.org/W4380263667"],"related_works":["https://openalex.org/W3108316206","https://openalex.org/W3090635032","https://openalex.org/W2509532614","https://openalex.org/W2895609091","https://openalex.org/W4200165338","https://openalex.org/W4398164744","https://openalex.org/W2906623831","https://openalex.org/W2979581376","https://openalex.org/W4411163229","https://openalex.org/W2895447346"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7125589136","counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2026-01-25T00:00:00"}
